$49.86
3.25% yesterday
NYSE, Nov 20, 09:18 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$49.90
+7.95 18.95% 1M
+20.94 72.31% 6M
+21.86 77.96% YTD
+25.48 104.34% 1Y
-9.16 15.51% 3Y
-3.10 5.85% 5Y
-3.10 5.85% 10Y
NYSE, Closing price Wed, Nov 20 2024
-1.63 3.16%
ISIN
US26622P1075
Symbol
DOCS

Key metrics

Market capitalization $9.32b
Enterprise Value $8.52b
P/E (TTM) P/E ratio 57.41
EV/FCF (TTM) EV/FCF 39.21
EV/Sales (TTM) EV/Sales 16.49
P/S ratio (TTM) P/S ratio 18.03
P/B ratio (TTM) P/B ratio 9.70
Revenue growth (TTM) Revenue growth 15.29%
Revenue (TTM) Revenue $516.85m
EBIT (operating result TTM) EBIT $202.96m
Free Cash Flow (TTM) Free Cash Flow $217.38m
Cash position $805.56m
EPS (TTM) EPS $0.87
P/E forward 60.03
P/S forward 17.26
EV/Sales forward 15.79
Short interest 8.78%
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Doximity forecast:

7x Buy
39%
11x Hold
61%

Analyst Opinions

18 Analysts have issued a Doximity forecast:

Buy
39%
Hold
61%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
517 517
15% 15%
100%
- Direct Costs 52 52
2% 2%
10%
465 465
18% 18%
90%
- Selling and Administrative Expenses 166 166
7% 7%
32%
- Research and Development Expense 86 86
2% 2%
17%
213 213
36% 36%
41%
- Depreciation and Amortization 10 10
19% 19%
2%
EBIT (Operating Income) EBIT 203 203
41% 41%
39%
Net Profit 174 174
41% 41%
34%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Positive
Seeking Alpha
6 days ago
I rate Doximity a buy with a price target of $65, reflecting a 24% upside due to strong Q2 earnings and favorable industry trends. Doximity's Q2 earnings showed impressive revenue growth, margin expansion, and a revised forecast of 36% CAGR in revenue and 74% CAGR in Adjusted EBITDA. Positioned at the intersection of healthcare trends, Doximity offers cost-saving solutions that align with indus...
Positive
The Motley Fool
13 days ago
The market loved what it saw from Doximity's second-quarter earnings.
Positive
Investopedia
13 days ago
Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 827
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today